Wearables and Remote Patient Monitoring — Continuous Glucose Monitors, Cardiac Monitors, and FDA-Cleared Consumer Health Devices

VPGMarketResearch
VP84695
$3,500.00

Wearable health devices and remote patient monitoring are generating continuous streams of physiological data — blood glucose, heart rate, blood oxygen, activity, and sleep — that are enabling proactive care interventions, chronic disease management improvements, and new reimbursement models for remote monitoring. Abbott's FreeStyle Libre and Dexcom's CGM systems have transformed diabetes management. Apple Watch's FDA-cleared ECG and irregular rhythm notifications represent the most commercially successful consumer health monitoring platform. Medicare reimbursement for remote physiologic monitoring has driven significant provider adoption of RPM programs for chronic conditions including hypertension, heart failure, and COPD.

This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.


Topics Covered
• RPM Market Dynamics
• Continuous Glucose Monitoring
• Cardiac Remote Monitoring
• Consumer Health Wearables
• Medicare RPM Reimbursement
• Payer Coverage and Integration
• RPM Platform Comparison

Table of Contents
1. Executive Summary
2. Technology Landscape Overview
3. RPM Market Dynamics
4. Continuous Glucose Monitoring
5. Cardiac Remote Monitoring
6. Consumer Health Wearables
7. Medicare RPM Reimbursement
8. Payer Coverage and Integration
9. RPM Platform Comparison
10. Competitive Landscape
11. Strategic Conclusions and Recommendations
12. Appendix

List of Tables
Table 1. Technology Overview and Key Data 2025
Table 2. RPM Market Dynamics
Table 3. Continuous Glucose Monitoring
Table 4. Cardiac Remote Monitoring
Table 5. Consumer Health Wearables
Table 6. Medicare RPM Reimbursement
Table 7. Payer Coverage and Integration
Table 8. RPM Platform Comparison
Table 9. Leading Companies — Technology Investment and Strategy 2025
Table 10. M&A and Partnership Activity 2023-2025
Table 11. Key Risks and Mitigation Strategies


 

List of Figures
Figure 1. Technology Landscape Map 2025
Figure 2. Competitive Position Map 2025
Figure 3. Investment Activity 2020-2025
Figure 4. Adoption Trajectory 2025-2030
Figure 5. OEM Program Comparison 2025
Figure 6. Strategic Opportunity Framework


 

Companies Profiled
Abbott
Apple
BioIntelliSense
Dexcom
Fitbit
Garmin
Insulet
iRhythm
Masimo
Medtronic

$3,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838